These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 14730620

  • 1. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I, Hasegawa M, Takehara K, Sato S.
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL.
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A, Peserico A, Rondinone R, Calligaro A, Del Ross T, Ghirardello A, Germino M, Todesco S.
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [Abstract] [Full Text] [Related]

  • 11. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
    Kuwana M, Kaburaki J, Medsger TA, Wright TM.
    Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
    [Abstract] [Full Text] [Related]

  • 12. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Böcher-Schwarz HG, Hainfellner J, Knosp E.
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T, Sato S, Hasegawa M, Ihn H, Takehara K.
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
    Kuwana M, Medsger TA, Wright TM.
    J Immunol; 1995 Sep 01; 155(5):2703-14. PubMed ID: 7650398
    [Abstract] [Full Text] [Related]

  • 20. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
    Henry PA, Atamas SP, Yurovsky VV, Luzina I, Wigley FM, White B.
    Arthritis Rheum; 2000 Dec 01; 43(12):2733-42. PubMed ID: 11145031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.